Critical Reviews in Oncology/Hematology
- ISSN:
- 1040-8428
0
h-index
0
Citations
5
Works
0.00
2-year mean citedness
Trust signals
1 of 3 signals presentIndependent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.
- DOAJNo datadoaj.org
- OAK listNo dataOAK
- Valid ISSNPresentISSN
This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.
Trends over time
Performance over time
Citation overview
Publications (bars) and citations (line) by year
- Publications
- Citations
Publication history
h-index evolution
Cumulative h-index by year
Most-cited works
- Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions20240 citations
- Phage therapy in cancer treatment: Mechanisms, emerging innovations, and translational progress20250 citations
- Epigenetic mechanisms and next-gen editing platforms in hematology: From molecular basis to therapeutic frontiers20250 citations
- Pharmacomicrobiomics in blood cancers: How the gut microbiome and its metabolites shape drug efficacy and toxicity20260 citations
- Overcoming conditional immune resistance in MSS and pMMR colorectal cancer: A sequential gating framework for immunotherapy20260 citations